| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |